Home > Insider Trading > Filing (0001562180-18-003488)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1192448	Glaukos Corp	GKOS	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1640771	M. Chris Calcaterra	C/O Glaukos Corporation 229 Avenida Fabricante San Clemente CA 92672	Chief Operating Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-08-02	38,983	$16.49	278,983	No	4	M	Direct
Common Stock	Disposition	2018-08-02	34,361	$44.31	244,622	No	4	S	Direct
Common Stock	Disposition	2018-08-02	4,522	$45.40	240,100	No	4	S	Direct
Common Stock	Disposition	2018-08-02	100	$46.29	240,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to buy)	Disposition	2018-08-02	38,983	$0.00	38,983	$16.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,417		2026-03-10	No	4	M	Direct

Footnotes

These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
This transaction was executed in multiple trades at prices ranging from $44.00 to $44.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $45.00 to $45.925. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option was granted on March 10, 2016, and has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date.